Tetanus is a life-threatening neurotoxic disease caused by Clostridium tetani, with clinical manifestations primarily attributed to tetanospasmin. However, the contribution of tetanolysin, a cholesterol-dependent cytolysin produced by C. tetani, remains poorly characterized. Here, we propose that tetanolysin plays a critical facilitating role in early tissue injury and toxin dissemination. Furthermore, we introduce a novel hypothesis that bioactive compounds derived from Lamium album, particularly phytoecdysteroids, may attenuate tetanolysin activity via antioxidant and lipid-modulating mechanisms. Given the cholesterol dependency of tetanolysin pore formation, modulation of membrane lipid dynamics represents a plausible therapeutic target. This perspective integrates bacterial toxin biology with phytochemical pharmacology and highlights tetanolysin as a potentially modifiable determinant of tetanus severity. Experimental validation of this hypothesis may open new avenues for adjunctive interventions in toxin-mediated bacterial diseases.